HSV Offers Promising Target for Preventive, Therapeutic Vaccines
Pharmacy Times
JANUARY 17, 2023
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
Vaccines Related Topics 
127 
Delaying, Skipping, and Altering Vaccine Schedules: Addressing Selective Vaccination
Pharmacy Times
OCTOBER 12, 2022
Pharmacists are poised to address selective vaccination and counsel patients contemplating delaying, skipping, or seeking an alternate vaccine schedule.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
UK, Moderna formalise 10-year vaccines alliance
Pharma Phorum
DECEMBER 22, 2022
Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna.
Promising RSV Vaccine Candidate Raises Hopes
Pharmacy Times
JANUARY 2, 2023
Pharmacists should educate patients about managing respiratory syncytial virus and let them know they may soon be able to get vaccinated.
Stay Up-to-Date on COVID-19 Vaccine, Boosters
Pharmacy Times
JANUARY 16, 2023
Recommendations vary based on age, first vaccination received, and time since the last dose.
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
Pharmacy Times
NOVEMBER 16, 2022
Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Vaccination Advocation Amid Misinformation
Pharmacy Times
JULY 22, 2022
Pharmacists discuss the impacts of inaccuracy on vaccine hesitancy and offer communication strategies for conversations with patients.
First Indian intranasal COVID-19 vaccine about to launch
Pharmafile
JANUARY 23, 2023
Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ the vaccine is the first of its kind to be developed in India.
Falling demand sees J&J scale back COVID-19 vaccine
Pharma Phorum
JANUARY 16, 2023
With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. Safety-wise, there was also the risk of a rare, but serious blood-clotting condition with the J&J vaccine that was a concern for some.
BMS settles lawsuit with two fired employees who refused COVID vaccines
Fierce Pharma
JANUARY 26, 2023
BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30
Multi- Year Global Vaccine Monitoring Project?
Fuld
NOVEMBER 29, 2022
A leading manufacturer of multiple infectious disease vaccines used Fuld & Company’s competitive monitoring services to gain a clear view of the evolving competitive landscape. ? The post Multi- Year Global Vaccine Monitoring Project? Background and Challenge.
mRNA can deliver universal flu vaccine, say US researchers
Pharma Phorum
NOVEMBER 25, 2022
Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of influenza that could form the basis of a future universal jab. The goals of the programme are also similar to those in COVID vaccine development.
Vaccine Surpluses Drive Acrimonious European Debates
PharmExec
JANUARY 11, 2023
Member states air concerns over excess supplies of COVID vaccines.
FDA starts speedy review of Takeda’s dengue vaccine
Pharma Phorum
NOVEMBER 23, 2022
The US regulator has started a priority, six-month review of Takeda’s dengue fever vaccine TAK-003 – tipped as a potential blockbuster product – making a decision likely in the first half of 2023. Takeda said last year that the vaccine could reach up to $1.6
COVID-19 Booster Vaccination Protection Rates
Pharmacy Times
NOVEMBER 11, 2022
Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.
Vaccines Offer Protection Against Cold and Cough Symptoms
Pharmacy Times
JANUARY 4, 2023
Pharmacists play a vital role in administering these and educating patients about COVID-19, influenza, pneumococcal, and Tdap vaccinations.
WuXi Vaccines to Debut New Vaccines Facility in China
Pharmaceutical Commerce
NOVEMBER 15, 2022
Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country.
Impact of SARS-CoV-2 Subvariants on Vaccination
Pharmacy Times
NOVEMBER 10, 2022
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.
Higher Incidence of Myocarditis, Pericarditis Found After COVID-19 Vaccination
Pharmacy Times
NOVEMBER 14, 2022
Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine
Fierce Pharma
JANUARY 25, 2023
Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16Moderna now in the crosshairs of Sens.
More vaccinated than unvaccinated died from COVID-19 in August: analysis
Fierce Healthcare
NOVEMBER 28, 2022
More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34
How Pfizer Delivered the COVID-19 Vaccine in Record Time
PharmExec
DECEMBER 22, 2022
Michael Ku, VP of global clinical supply at Pfizer, shares insights for the c-suite as well as reveals behind-the-scenes insight into Pfizer’s ability to deliver a COVID-19 vaccine swiftly.
First needle-free COVID-19 vaccine patch
European Pharmaceutical Review
NOVEMBER 9, 2022
Vaxxas, a biotechnology company has announced the start of its Phase I clinical trial of a needle-free COVID-19 vaccine, delivered via a high-density microarray patch (HD-MAP), giving potential coverage of all major SARS-CoV-2 variants. Research data on the innovative COVID-19 vaccine patch.
Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox
Pharmacy Times
JANUARY 27, 2023
Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.
Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Shows Positive Early Trial Results
Pharmacy Times
OCTOBER 18, 2022
Research showed the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (Pfizer-BioNTech) increases neutralizing antibody response against multiple variants of Omicron.
Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'
Fierce Pharma
DECEMBER 14, 2022
Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. fkansteiner. Wed, 12/14/2022 - 09:00
Pfizer bivalent COVID-19 vaccine starts rollout
Pharma Phorum
SEPTEMBER 6, 2022
The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week.
Dengue Vaccine: What Pharmacists Need to Know
Pharmacy Times
JUNE 27, 2022
The FDA approved the first vaccine for dengue disease in May 2019.
Digital innovation drives vaccine development
Pharma Phorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. The importance of vaccine awareness and access.
AstraZeneca’s intranasal COVID vaccine fails first clinical test
Pharma Phorum
OCTOBER 11, 2022
An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus.
Moderna’s HIV vaccine prepped for trials in Africa
Pharma Phorum
MAY 19, 2022
Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt. They will be followed for six months to gauge the safety and immunogenicity of the vaccine.
FDA Approves Vaccine to Prevent Whooping Cough in Newborns by Vaccinating Mothers at Third Trimester
Pharmacy Times
OCTOBER 7, 2022
The vaccine prevents whooping cough in infants younger than 2 months. It can be safely administered to mothers who are in their third trimester.
Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects
Pharmafile
JANUARY 13, 2023
The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known severe “adverse events of special interest” (AESIs) which appeared in post-vaccination studies.
Prosecutor confirms probe into Europe's COVID-19 vaccine purchasing
Fierce Pharma
OCTOBER 17, 2022
Prosecutor confirms probe into Europe's COVID-19 vaccine purchasing. zbecker. Mon, 10/17/2022 - 15:37
FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data
Fierce Pharma
JANUARY 27, 2023
FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data kdunleavy Fri, 01/27/2023 - 10:01
Combination Flu, COVID-19, RSV mRNA Vaccine Could Change Immunizations Landscape
Pharmacy Times
AUGUST 23, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.
Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial
Pharma Phorum
DECEMBER 14, 2022
The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The post Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial appeared first on.
Takeda gets first approval for its dengue vaccine
Pharma Phorum
AUGUST 23, 2022
Japan’s Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product. Qdenga is also the first of the company’s vaccine products to be marketed outside Japan.
Pharmacists Play Pivotal Role in Flu Vaccines
Pharmacy Times
SEPTEMBER 14, 2022
Key responsibilities include providing recommendations, administering vaccinations, disseminating evidence-based advice, reducing spread of influenza in communities.
Study Finds New Insights in Young Adults Who Develop Myocarditis After COVID-19 Vaccination
Pharmacy Times
JANUARY 12, 2023
The risk of severe COVID-19 continues to outweigh the rare risk of post-vaccination myocarditis.
Cancer vaccines: providing the edge in oncology
Pharma Phorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines.
Johnson & Johnson scale back COVID-19 vaccination production
Pharmafile
JANUARY 17, 2023
US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the past few months. As part of this, they’ve started terminating manufacturing agreements with companies who helped them produce the vaccine, such as Catalent and Sanofi. read more. Manufacturing and Production
Cancer Vaccine May be Effective for Melanoma Patients
Pharmacy Times
OCTOBER 17, 2022
A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.
Let's personalize your content